Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-18-009832
Filing Date
2018-04-30
Accepted
2018-04-30 16:11:21
Documents
5
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A scph-defa14a_20180430.htm DEFA14A 54078
2 GRAPHIC g2018042522004651722008.jpg GRAPHIC 48250
3 GRAPHIC g2018042522004656422011.jpg GRAPHIC 25818
4 GRAPHIC g2018042522004653922009.jpg GRAPHIC 56202
5 GRAPHIC g2018042522004655322010.jpg GRAPHIC 23751
  Complete submission text file 0001564590-18-009832.txt   267848
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38293 | Film No.: 18789803
SIC: 2834 Pharmaceutical Preparations